Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications ...

Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.

The drug is now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as ...

As the popularity of medications for weight loss, such as Ozempic and Wegovy, surges across North America, new research ...

EXPERTS have revealed the golden dose of Mounjaro that helps shift the most weight – and it’s not the highest one. Weight ...

The move follows a dramatic breakup in June between Hims & Hers and Danish drug maker Novo Nordisk, which makes the brand name weight loss drug Wegovy. Novo Nordisk accused the Hims & Hers of ...

Novo Nordisk seeks EMA approval for 7.2 mg Wegovy dose after trials show 21% weight loss in people with obesity and type 2 diabetes.

Researchers say GLP-1 medicines might be able to help with migraines.

The drug coverage provision does not mention any specific drug by name, but it could include the GLP-1 agonists, such as ...

Danish drugmaker Novo Nordisk is working to bring its blockbuster drug Ozempic to India “as soon as possible", Dr Yan Cai, ...

Novo Nordisk submits a higher 7.2 mg dose of Wegovy for EMA approval, backed by trials showing 21% weight loss in obesity and ...